Impel Pharmaceuticals Inc., along with its affiliate, filed a motion for joint administration of their Chapter 11 bankruptcy cases in the US Bankruptcy Court on December 19, 2023. As per the motion, the debtor seeks the joint administration of the cases of its affiliate, Impel NeuroPharma Australia Pty Ltd, with its own case for administrative and procedural purposes. Impel Pharmaceuticals Inc. has been proposed as the lead debtor.